New Fetoscopes for Fetal Disorders
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test the safety and feasibility of performing surgery on babies before birth using new fetoscopes, which are special tools for in-womb surgery. The goal is to determine if these improved tools can treat certain fetal conditions while still in the womb. Pregnant women who are healthy enough for surgery and have planned surgical procedures may be suitable candidates for this study. Participants must understand and agree to the risks involved in these procedures.
As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could enhance fetal surgery techniques.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that these new fetoscopes are safe for fetal surgery?
Researchers are conducting studies to ensure the safety of the Karl Storz New Generation Fetoscope, a tool for surgeries on babies still in the womb. These fetoscopes help doctors see and reach the fetus more easily. Although new and not yet FDA-approved, researchers aim to confirm their safety and effectiveness.
Currently, specific safety data from these studies is unavailable. However, since the trial focuses on testing the safety and practicality of the fetoscopes, gathering detailed safety information remains a top priority. As researchers test the fetoscopes for safety, potential participants can be assured that the study will address any safety concerns.12345Why are researchers excited about this trial?
The Karl Storz New Generation Fetoscope is unique because it offers a cutting-edge approach to fetal surgery by allowing precise in utero procedures for conditions that can be treated with fetoscopy. Unlike traditional methods that may rely on more invasive surgeries, this fetoscope is designed to minimize invasiveness while increasing surgical accuracy. Researchers are excited about this treatment because it has the potential to improve outcomes for both the fetus and the mother by reducing risks associated with more invasive surgical procedures.
What evidence suggests that the Karl Storz fetoscopes are effective for fetal disorders?
Research shows that the Karl Storz New Generation Fetoscope improves the accuracy of surgeries on babies while still in the womb. This tool lets doctors see and reach the baby directly inside the mother's body. Previous studies have shown that it helps diagnose and treat conditions in unborn babies. The new features of the fetoscope aim to improve surgery results by giving doctors a clearer view and better access. In this trial, participants will undergo in utero surgery using the new generation Karl Storz fetoscopes to assess its safety and practicality. The device looks promising because of its improved design compared to older models.12345
Who Is on the Research Team?
Mauro Schenone, MD
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
This trial is for pregnant individuals whose babies have been diagnosed with conditions that could potentially be treated through surgery before birth. Specific eligibility details are not provided, but typically participants would need to meet certain health standards and the fetus must be at a stage where in utero surgery is possible.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo in utero surgery using the new generation Karl Storz fetoscopes for fetal conditions amenable to treatment with fetoscopy
Follow-up
Participants are monitored for safety and effectiveness after the in utero surgery
What Are the Treatments Tested in This Trial?
Interventions
- Karl Storz New Generation Fetoscope
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor